» Articles » PMID: 21728172

Double- and Monofunctional CD4⁺ and CD8⁺ T-cell Responses to Mycobacterium Tuberculosis DosR Antigens and Peptides in Long-term Latently Infected Individuals

Overview
Journal Eur J Immunol
Date 2011 Jul 6
PMID 21728172
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

More than 2 billion individuals are latently infected with Mycobacterium tuberculosis (Mtb). Knowledge of the key Mtb antigens and responding T-cell subsets mediating protection against Mtb is critical for developing improved tuberculosis (TB) vaccines. We previously reported that Mtb DosR-regulon-encoded antigens are recognized well by human T cells in association with control of Mtb infection. The characteristics of the responding T-cell subsets, however, remained unidentified. We have therefore studied the cytokine production and memory phenotypes of Mtb DosR-regulon-encoded antigen-specific T cells from individuals who had been infected with Mtb decades ago, yet never developed TB (long-term latent Mtb-infected individuals). Using multi-parameter flow cytometry and intracellular cytokine staining for IFN-γ, TNF-α and IL-2, we found double and single cytokine-producing CD4(+) as well as CD8(+) T cells to be the most prominent subsets, particularly IFN-γ(+) TNF-α(+) CD8(+) T cells. The majority of these T cells comprised effector memory and effector T cells. Furthermore, CFSE labeling revealed strong CD4(+) and CD8(+) T-cell proliferative responses induced by several "immunodominant" Mtb DosR antigens and their specific peptide epitopes. These findings demonstrate the prominent presence of double- and monofunctional CD4(+) and CD8(+) T-cell responses in naturally protected individuals and support the possibility of designing Mtb DosR antigen-based TB vaccines.

Citing Articles

In-silico development of a novel TLR2-mediating multi-epitope vaccine against .

Singh S, Verma P, Gaur M, Bhati L, Madan R, Sharma P In Silico Pharmacol. 2025; 13(1):34.

PMID: 40018380 PMC: 11861476. DOI: 10.1007/s40203-025-00322-8.


HBHA induces IL-10 from CD4+ T cells in patients with active tuberculosis but IFN-γ and IL-17 from individuals with infection.

Izumida M, Jobe H, Coker E, Barry A, Rashid M, Manneh I Front Immunol. 2024; 15:1422700.

PMID: 39257584 PMC: 11384583. DOI: 10.3389/fimmu.2024.1422700.


Tuberculosis Vaccines and T Cell Immune Memory.

Li F, Dang W, Du Y, Xu X, He P, Zhou Y Vaccines (Basel). 2024; 12(5).

PMID: 38793734 PMC: 11125691. DOI: 10.3390/vaccines12050483.


Construction of novel multi-epitope-based diagnostic biomarker HP16118P and its application in the differential diagnosis of Mycobacterium tuberculosis latent infection.

Wang J, Jiang F, Cheng P, Ye Z, Li L, Yang L Mol Biomed. 2024; 5(1):15.

PMID: 38679629 PMC: 11056354. DOI: 10.1186/s43556-024-00177-z.


Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development.

Chugh S, Bahal R, Dhiman R, Singh R NPJ Vaccines. 2024; 9(1):57.

PMID: 38461350 PMC: 10924964. DOI: 10.1038/s41541-024-00834-y.